Literature DB >> 25561758

New 'multi-omics' approach and its contribution to hepatocellular carcinoma in China.

Yoshinori Inagaki1, Peipei Song1, Norihiro Kokudo1, Wei Tang1.   

Abstract

Entities:  

Year:  2014        PMID： 25561758      PMCID： PMC4279209          DOI： 10.3978/j.issn.1000-9604.2014.11.07

Source DB:  PubMed          Journal:  Chin J Cancer Res        ISSN： 1000-9604            Impact factor:   5.087


× No keyword cloud information.
  13 in total

1.  Aberrant stratifin overexpression is regulated by tumor-associated CpG demethylation in lung adenocarcinoma.

Authors:  Aya Shiba-Ishii; Masayuki Noguchi
Journal:  Am J Pathol       Date:  2012-02-04       Impact factor: 4.307

2.  Standardizing management of hepatocellular carcinoma in China: devising evidence-based clinical practice guidelines.

Authors:  Peipei Song
Journal:  Biosci Trends       Date:  2013-10       Impact factor: 2.400

Review 3.  Biomarkers: evaluation of screening for and early diagnosis of hepatocellular carcinoma in Japan and china.

Authors:  Peipei Song; Jianjun Gao; Yoshinori Inagaki; Norihiro Kokudo; Kiyoshi Hasegawa; Yasuhiko Sugawara; Wei Tang
Journal:  Liver Cancer       Date:  2013-01       Impact factor: 11.740

4.  Clinical utility of simultaneous measurement of alpha-fetoprotein and des-γ-carboxy prothrombin for diagnosis of patients with hepatocellular carcinoma in China: A multi-center case-controlled study of 1,153 subjects.

Authors:  Peipei Song; Xiaobin Feng; Yoshinori Inagaki; Tianqiang Song; Keming Zhang; Zhigang Wang; Shuguo Zheng; Kuansheng Ma; Qiang Li; Dalu Kong; Qiang Wu; Ti Zhang; Xin Zhao; Kiyoshi Hasegawa; Yasuhiko Sugawara; Norihiro Kokudo; Wei Tang
Journal:  Biosci Trends       Date:  2014-10       Impact factor: 2.400

5.  Systematic evidence-based clinical practice guidelines are ushering in a new stage of standardized management of hepatocellular carcinoma in Japan.

Authors:  Peipei Song; Wei Tang; Kiyoshi Hasegawa; Norihiro Kokudo
Journal:  Drug Discov Ther       Date:  2014-04

6.  Current clinical uses of the biomarkers for hepatocellular carcinoma.

Authors:  Jiwei Huang; Yong Zeng
Journal:  Drug Discov Ther       Date:  2014-04

7.  Screening for and surveillance of high-risk patients with HBV-related chronic liver disease: promoting the early detection of hepatocellular carcinoma in China.

Authors:  Peipei Song; Xiaobin Feng; Keming Zhang; Tianqiang Song; Kuansheng Ma; Norihiro Kokudo; Jiahong Dong; Linong Yao; Wei Tang
Journal:  Biosci Trends       Date:  2013-02       Impact factor: 2.400

8.  Bub1 overexpression induces aneuploidy and tumor formation through Aurora B kinase hyperactivation.

Authors:  Robin M Ricke; Karthik B Jeganathan; Jan M van Deursen
Journal:  J Cell Biol       Date:  2011-06-06       Impact factor: 10.539

9.  Expression and function analysis of mitotic checkpoint genes identifies TTK as a potential therapeutic target for human hepatocellular carcinoma.

Authors:  Xiao-Dong Liang; Yue-Chu Dai; Zhao-Yun Li; Mei-Fu Gan; Shi-Rong Zhang; Hong-Sheng Lu; Xue-Quan Cao; Bei-jia Zheng; Ling-Fen Bao; Dan-Dan Wang; Li-Ming Zhang; Sheng-Lin Ma
Journal:  PLoS One       Date:  2014-06-06       Impact factor: 3.240

Review 10.  The '-omics' revolution and oesophageal adenocarcinoma.

Authors:  Jamie M J Weaver; Caryn S Ross-Innes; Rebecca C Fitzgerald
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-08-27       Impact factor: 46.802
View more
  1 in total

1.  Nestin overexpression in hepatocellular carcinoma associates with epithelial-mesenchymal transition and chemoresistance.

Authors:  Yan Zhang; Shan Zeng; Junli Ma; Ganlu Deng; Yanlin Qu; Cao Guo; Hong Shen
Journal:  J Exp Clin Cancer Res       Date:  2016-07-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.